Virometix (private company)
See something wrong or missing? Let us know
Offices:Schlieren
Industry:BiotechHealth services
Business model:B2B
Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases
values in USD
Investments 8.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Virometix
Name | Criteria | |
---|---|---|
![]() |
Abzena
42%
|
|
![]() |
Antag Therapeutics
42%
|
|
![]() |
Antelope Dx
42%
|
|
![]() |
Arthex Biotech S.L.
42%
|
|
![]() |
Cebiotex
42%
|
|
![]() |
Cell-Easy
42%
|
|
![]() |
CysBio
42%
|
|
![]() |
Eagle Genomics
42%
|
|
![]() |
Elypta
42%
|
|
![]() |
GeneMe
42%
|
|